Royalty Pharma (RPRX)
(Delayed Data from NSDQ)
$27.74 USD
-0.43 (-1.51%)
Updated Apr 22, 2024 11:56 AM ET
3-Hold of 5 3
C Value D Growth A Momentum C VGM
Industry / Sector Report
Industry : Financial - Miscellaneous Services
Zacks Industry Rank
Top 37% (94 out of 252)Zacks Sector Rank
Top 44% (7 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.21 | 1.69 | 9.99 |
Current Quarter Estimate | 0.96 | 7.09 | 60.00 |
Year Ago Quarter Estimate | 1.60 | 4.55 | 52.54 |
Next Quarter Estimate | 0.90 | 6.89 | 61.00 |
Next Year Estimate | 4.32 | 34.78 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -12.03 | 10.30 | 17.08 |
Next Year | 9.37 | 16.60 | 8.00 |
Last 5 Years | NA | 5.80 | 8.10 |
Next 5 Years | NA | 18.70 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 6.34 | 13.52 |
Price/Book (MRQ) | 1.65 | 0.99 |
Price/Cash Flow (MRFY) | 6.09 | 7.79 |
Dividend Yield | 3.02% | 0.00% |
Net Profit Margin (TTM) | 48.22% | 5.90% |
Return on Equity (TTM) | 26.93% | 4.41% |
Debt to Equity (MRQ) | NA | 43.62 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.